Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisia HealthcareNZSE:PHL +5.63%31 Return-on-Tangible-Equity is 54.93% as of Mar. 2026, which is 1672% above its 10-year median of 3.10. GuruFocus rates NZSE:PHL with a GF Score™ of 31/100 and a GF Value™ of NZ$0.42 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 576 Healthcare Providers & Services companies, Promisia Healthcare ranks better than 75.87% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Promisia Healthcare's annualized net income for the quarter that ended in Mar. 2026 was NZ$25.94 Mil. Promisia Healthcare's average shareholder tangible equity for the quarter that ended in Mar. 2026 was NZ$47.23 Mil. Therefore, Promisia Healthcare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 54.93%.
The historical rank and industry rank for Promisia Healthcare's Return-on-Tangible-Equity or its related term are showing as below:
NZSE:PHL'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -1285.91 Med: 3.1 Max: 28.99
Current: 28.99
During the past 13 years, Promisia Healthcare's highest Return-on-Tangible-Equity was 28.99%. The lowest was -1,285.91%. And the median was 3.10%.
NZSE:PHL's Return-on-Tangible-Equity is ranked better than 75.87% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.505
vs NZSE:PHL: 28.99
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Promisia Healthcare Return-on-Tangible-Equity Related Terms
Promisia Healthcare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Promisia Healthcare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:PHL vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Promisia Healthcare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisia Healthcare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Promisia Healthcare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Promisia Healthcare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 54.93% mean?
Promisia Healthcare (NZSE:PHL) has a Return-on-Tangible-Equity of 54.93% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Promisia Healthcare and its competitors. This is 1672% above median its historical median of 3.10. According to the industry distribution chart, Promisia Healthcare ranks #139 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 24.1%.
Is Promisia Healthcare's Return-on-Tangible-Equity too high?
Promisia Healthcare's current Return-on-Tangible-Equity of 54.93% is 1672% above median its 10-year median of 3.10. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.51. Promisia Healthcare's value of 54.93% is 422.9% above this industry median. Based on the distribution chart, Promisia Healthcare ranks #139 out of 576 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Promisia Healthcare has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Promisia Healthcare's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Promisia Healthcare ranks #139 out of 576 companies for Return-on-Tangible-Equity. This places Promisia Healthcare in the top 24% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.51. Promisia Healthcare's value of 54.93% is 422.9% above this benchmark. While the company's 10-year median is 3.10 vs. the industry median of 10.51, Promisia Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.51, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Promisia Healthcare's current Return-on-Tangible-Equity of 54.93% is 422.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Promisia Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisia Healthcare's current Return-on-Tangible-Equity is 54.93%, which is 1672% above median its own 10-year median of 3.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisia Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Promisia Healthcare (NZSE:PHL) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.42, compared to a current price of NZ$0.75 — trading 78.6% above its estimated fair value. The current Return-on-Tangible-Equity is 54.93%, which is 1672% above median its 10-year median of 3.10 and 422.9% above the Healthcare Providers & Services industry median of 10.51. Promisia Healthcare's overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Promisia Healthcare (NZSE:PHL), the current Return-on-Tangible-Equity is 54.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Promisia Healthcare (NZSE:PHL) Overvalued in 2026?
Based on GuruFocus' analysis, Promisia Healthcare stock appears to be overvalued.
The current stock price of NZ$0.75 is trading 78.6% above its estimated GF Value™ of NZ$0.42.
GuruFocus considers Promisia Healthcare to be Significantly Overvalued.
Key valuation signals for NZSE:PHL:
Return-on-Tangible-Equity: 54.93% (1672% above median its 10-year median of 3.10)
GF Value™: NZ$0.42 vs. price of NZ$0.75 (78.6% above fair value)
Industry Position: 422.9% above the Healthcare Providers & Services median (#139 of 576)
No single metric tells the full story. See the NZSE:PHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Promisia Healthcare Ltd is engaged in the provision of aged care in New Zealand. The company's services include Resthome Care, Hospital (Continuing) Care, Respite (Short Term) Care, Young Disabled Care, Dementia Care, and others. The Group operates in one operating segment: the provision of aged care in New Zealand.
31GF Score
Get the complete analysis for NZSE:PHL
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:PHL has been successfully added to your 
